Sale of HCP and BBL
Sale of HCP (REITs and MLPs strategy) and BBL (Ex-US strategy) due to poor future dividend growth prospects.
Sale of HCP and BBL Read More »
Sale of HCP (REITs and MLPs strategy) and BBL (Ex-US strategy) due to poor future dividend growth prospects.
Sale of HCP and BBL Read More »
As part of my "Ex-US International ETFs and Dividend Stocks" strategy, purchase of Bhp Billiton Plc (NYSE:BBL).
Purchase of Bhp Billiton Plc (NYSE:BBL) Read More »
Discover the nine new stocks I now follow as part of my investment strategies, including giants like GlaxoSmithKline and HSBC. With a total of 133 dividend growth stocks, tap into the potential of stocks traded on the London Stock Exchange, where dividends are exempt from withholding tax.
7 new titles followed Read More »